The Scientist

» drug development, ecology and evolution

Most Recent

image: Yeast Genome Doubling

Yeast Genome Doubling

By | August 10, 2015

The results of a computational genetic analysis suggest Saccharomyces cerevisiae doubled its genome through species hybridization.


image: Investigating the Four-legged Snake Fossil

Investigating the Four-legged Snake Fossil

By | August 5, 2015

Brazilian officials are trying to determine whether the transformational fossil find was exported illegally from the country.

1 Comment

image: FDA Approves 3-D–Printed Drug

FDA Approves 3-D–Printed Drug

By | August 4, 2015

The US Food and Drug Administration green lights the first medicine produced by a 3-D printer for use in the human body.

1 Comment

image: Opinion: Life’s X Factor

Opinion: Life’s X Factor

By | August 4, 2015

Did endosymbiosis—and the innovations in membrane bioenergetics it engendered—make it possible for eukaryotic life to evolve?

1 Comment

image: Mimicry Muses

Mimicry Muses

By | August 1, 2015

The animal world is full of clever solutions to bioengineering challenges.


image: Teva Buys Allergan Generics for $40.5 Billion

Teva Buys Allergan Generics for $40.5 Billion

By | July 27, 2015

Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal. 


image: EMA Green Lights Malaria Vax

EMA Green Lights Malaria Vax

By | July 27, 2015

The European Medicines Agency endorses the first-ever malaria vaccine for use in children 6 weeks to 17 months old.


image: Four-legged Snake Fossil Found

Four-legged Snake Fossil Found

By | July 27, 2015

Researchers discover an unprecedented paleontological relic that may just rewrite the book on snake evolution.


image: Warming Climate Hurt Megafauna?

Warming Climate Hurt Megafauna?

By | July 27, 2015

The massive mammals that roamed Earth some 30,000 years ago may have gone extinct as a result of global warming, according to an ancient-DNA study.

1 Comment

image: HHS Partners on Ebola Drug

HHS Partners on Ebola Drug

By | July 22, 2015

The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.


Popular Now

  1. Antidepressant Exerts Epigenetic Changes
  2. Inside a Lab Mouse’s High-Fat Diet
  3. Image of the Day: Mother’s Love
  4. Remote Mind Control
Life Technologies